ATRC

AtriCure, Inc.

33.62 USD
+0.18 (+0.54%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

AtriCure, Inc. stock is down -9.23% since 30 days ago. The next earnings date is Feb 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.16% of the previous 18 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Nov 20:20 19 Jan, 2024 55.00 PUT 35 0

About AtriCure, Inc.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue and systems, and intercostal nerves. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products. CryoICE Cryoablation System enables the user to make linear ablations of varied lengths. EPi-Sense Guided Coagulation System is used to treat persistent atrial fibrillation.

  • JP Morgan
    Wed Nov 29, 10:43
    buy
    confirm
  • Needham
    Wed Nov 29, 04:30
    buy
    confirm